Literature DB >> 19653965

Transient cardiac arrhythmias related to lopinavir/ritonavir in two patients with HIV infection.

Santosh K Chaubey1, Ashim K Sinha, Elizabeth Phillips, Darren B Russell, Henrik Falhammar.   

Abstract

A 42-year-old Thai man was administered the combination drugs liponavir/ritonavir and abacavir/lamivudine. On day 3 he was admitted and his electrocardiogram demonstrated sinus arrest with junctional escape rhythm with a rate of 42 min(-1). Three days after stopping the medication he reverted to normal sinus rhythm. A 55-year-old Caucasian man was admitted to hospital with triple vessel disease. He had a permanent pacemaker inserted 4 years previously for Mobitz type II AV block detected on stress electrocardiogram, which developed 1 month after initiation of lopinavir/ritonavir. These two cases highlight the importance of considering lopinavir/ritonavir induced arrhythmias when dealing with HIV-positive individuals.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19653965     DOI: 10.1071/SH09005

Source DB:  PubMed          Journal:  Sex Health        ISSN: 1448-5028            Impact factor:   2.706


  7 in total

1.  Sinus bradycardia induced by darunavir-ritonavir in a patient with acquired immunodeficiency syndrome.

Authors:  J A Gonzales Zamora; L A Espinoza
Journal:  Infection       Date:  2017-09-01       Impact factor: 3.553

Review 2.  Cardiovascular Safety of Potential Drugs for the Treatment of Coronavirus Disease 2019.

Authors:  Gaurav Aggarwal; Brandon Michael Henry; Saurabh Aggarwal; Sripal Bangalore
Journal:  Am J Cardiol       Date:  2020-05-16       Impact factor: 2.778

3.  Potentially fatal severe brady arrythmias related to Lopinavir-Ritonavir in a COVID 19 patient.

Authors:  Venkatesan Shree; Lydia Qi En Liew; Wei Wei Teo; Jeanette Ting; Mei Fong Liew
Journal:  J Microbiol Immunol Infect       Date:  2020-08-06       Impact factor: 4.399

Review 4.  Geriatric challenges in the new coronavirus disease-19 (COVID-19) pandemic: A systematic review.

Authors:  Masoumeh Mohamadi; Azadeh Goodarzi; Armin Aryannejad; Nima Fattahi; Mahtab Alizadeh-Khoei; Shahnaz Miri; Hamidreza Hekmat; Moloud Payab; Mohammad Bodaghabadi
Journal:  Med J Islam Repub Iran       Date:  2020-09-17

Review 5.  Arrhythmias in COVID-19.

Authors:  Summit Pandat; Zhihao Zhu; Stephanie Fuentes-Rojas; Paul Schurmann
Journal:  Methodist Debakey Cardiovasc J       Date:  2021-12-15

6.  Investigating and Resolving Cardiotoxicity Induced by COVID-19 Treatments using Human Pluripotent Stem Cell-Derived Cardiomyocytes and Engineered Heart Tissues.

Authors:  He Xu; Ge Liu; Jixing Gong; Ying Zhang; Shanshan Gu; Zhongjun Wan; Pengcheng Yang; Yage Nie; Yinghan Wang; Zhan-Peng Huang; Guanzheng Luo; Zhongyan Chen; Donghui Zhang; Nan Cao
Journal:  Adv Sci (Weinh)       Date:  2022-09-02       Impact factor: 17.521

7.  COVID-19 treatment with lopinavir-ritonavir resulting in sick sinus syndrome: a case report.

Authors:  Laureen Yi-Ting Wang; Gavin Yeow Ping Ng
Journal:  Eur Heart J Case Rep       Date:  2020-06-30
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.